|
|
Volumn 2013, Issue , 2013, Pages 493138-
|
|
Tregitope peptides: the active pharmaceutical ingredient of IVIG?
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
EPITOPE;
IMMUNOGLOBULIN;
PEPTIDE;
ANIMAL;
AUTOIMMUNE DISEASE;
CD4+ T LYMPHOCYTE;
CD8+ T LYMPHOCYTE;
DRUG EFFECT;
HUMAN;
IMMUNOLOGICAL TOLERANCE;
IMMUNOLOGY;
LYMPHOCYTE ACTIVATION;
METABOLISM;
REGULATORY T LYMPHOCYTE;
REVIEW;
ANIMALS;
AUTOIMMUNE DISEASES;
CD4-POSITIVE T-LYMPHOCYTES;
CD8-POSITIVE T-LYMPHOCYTES;
EPITOPES, T-LYMPHOCYTE;
HUMANS;
IMMUNE TOLERANCE;
IMMUNOGLOBULINS, INTRAVENOUS;
LYMPHOCYTE ACTIVATION;
PEPTIDES;
T-LYMPHOCYTES, REGULATORY;
MLCS;
MLOWN;
|
|
EID: 84905391997
PISSN: None
EISSN: 17402530
Source Type: Journal
DOI: 10.1155/2013/493138 Document Type: Review |
|
Times cited : (23)
|
|
References (0)
|
